Pharmadule Morimatsu Awarded Modular Biomanufacturing Facility


Pharmadule Morimatsu Awarded Modular Biomanufacturing Facility


Pharmadule Morimatsu Logo 150 x 48

Press Release | Pharmadule Morimatsu AB

OCTOBER 01, 2018

Nacka, Stockholm: – Pharmadule Morimatsu has been awarded the contract for design, fabrication, site installation and start-up of a state-of-the-art modular biomanufacturing plant in the US. The basic design was completed earlier this year and delivery and completion is scheduled for 2019. The owner will leverage the off-site fabrication of modular construction and complete site work in parallel to optimize the overall schedule and begin qualification and production activities much earlier than can be achieved with conventional stick-built construction. This will allow the owner to more quickly gain a return on investment.

Pharmadule Morimatsu AB is the Swedish-based founder and global leader in the delivery of modular facilities to the Life Sciences Industry. Utilizing multidisciplinary expertise, including Process and Facility Engineering, Pharmadule is able to provide turnkey solutions anywhere in the world quickly, efficiently and cost effectively.

About Pharmadule Morimatsu


Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready-made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.

Since then, Pharmadule has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pfizer, AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, which specializes in process equipment, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.

Media Contact

Leo Fällgren, Director Business Development, Pharmadule Morimatsu AB
Tel: +46 (0)8 587 42 000
Email: Leo.Fallgren@pharmadule.com

Resources

Click on Pharmadule Morimatsu Awarded Modular Biomanufacturing Facility for more information.
Click on Pharmadule to contact the company directly.


Supplier Information
Supplier: Pharmadule Morimatsu AB
Address: DanvikCenter 28, SE – 131 30 Nacka, Sweden
Tel: +46 (0)8 587 42 000
Website: www.pharmadule.com


Comments are closed.